Menu

1.800.860.4519

Sign In Get Started

Logo
Galectin Therapeutics

Corporation

Norcross, Georgia HQ

Member since
2013
Deals they've closed
1
About
Galectin Therapeutics, Inc. (NASDAQ: GALT) is the leading developer of compounds that target galectin proteins to treat fibrosis and cancer. Building upon positive preclinical studies in animals, the company’s primary focus is on NASH (non-alcoholic steatohepatitis) with advanced fibrosis and cirrho…
Team (1)
Recent Transactions (1)
Galectin Therapeutics
Research and Development in Biotechnology
Advised

Galectin Therapeutics

in securing investment from

Institutional investors

November 2015

Sectors Galectin Therapeutics serves:
Life Sciences

Join Axial's Private M&A Platform

Galectin Therapeutics connects with qualified M&A advisors through the Axial Platform.

Looking for Buyers?

Reach this investor and hundreds more on Axial. No cost to advisors.

Join as Advisor

Selling Your Company?

Find the perfect advisor to help you sell your business.

Join as Owner

Double opt-in matching process ensures qualified connections

Member since
2013
Deals they've closed
1
Team (1)
Join as Advisor Join as Owner